Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

M.tuberculosis H37Rv: Control vs. anti-TB compound treated

ABSTRACT: To monitor the anti-tuberculosis compound IMB-YH-8 induced gene response profile at an early stage, we treated logarithmically growing M. tuberculosis with IMB-YH-8 at the concentration of 2.5 μg/ml throughout the first 4 hr.

ORGANISM(S): Mycobacterium tuberculosis

PROVIDER: GSE90858 | GEO | 2016/12/06

SECONDARY ACCESSION(S): PRJNA356220

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Proteomic profiling of culture filtrates from M.tuberculosis H37Rv

Project description:In this report, a novel tandem cascade of biomimetic affinity chromatography (BiAC) system was used to fractionate the culture filtrate proteins (CFPs) of M. tuberculosis (MTB) prior to LC-MS/MS analysis. Consequently, in fractionations by 6 BiAC columns, 541 proteins from CFPs were identified using stringent database research by Mascot and scaffold software with ƿ < 0.05, each protein was determined with two distinct peptide sequences. And 248 proteins were identified in un-fractionated culture filtrates. Compared with un-fractionated sample, both proteomic coverage and accuracy of MS analysis were remarkably improved using BiAC fractionations. In 242 identifications by both BiAC fractionations and un-fractionated samples, the average number of matched peptide sequence was increased from 14 hits to 44 hits after BiAC fractionation. The average coverage of peptide sequence of these 242 proteins was also increased from 19.6% (un-fractionation) to 26.1% (fractionation). Compared with previous identifications in CFPs, 11.15% (61/547) identifications in this study have not been reported. The majority of these newly identifications possess extremely biochemical characteristics that usually are not suitable be fractionated by gel-based proteomic approach, of which 12 proteins with Mw<10kDa or Mw>140kDa, 10 with pI<4.0 or pI>10. And 20 membrane proteins, of which have 9 with 2-14 transmembrane domains. Taken together, the BiAC system can enhance the proteomic detection coverage especially by reducing the complexity of sample, improving the low copy and extremely biochemical characteristic proteins.

2018-07-05 | PXD005290 | Pride

Project description:WTCCC project Tuberculosis (TB) samples

| EGAD00000000016 | EGA

Development of gene expression signatures for latent and clinical tuberculosis (TB)

Project description:For further identify the differentiation between latent and clinical tuberculosis (TB), we employed whole genome microarray expression profiling to study genes with significant expression change in peripheral CD4+T cells between healthy control, latent tuberculosis (LTB) and clinical tuberculosis (TB). Our experiment included 4 groups: healthy donor (HD), latent TB1 (LTB1) with low IFN-gamma release level, latent TB2 (LTB2) with high IFN-gamma release level, and tuberculosis (TB) with high IFN-gamma release level. Human peripheral blood mononuclear cells were collected, from which CD4+T cells were isolated. Total RNA of each individuals of each group was extracted from peripheral CD4+T cells. One μg of RNA mixture, pooled equivalently by each individual total RNA of each group, was administrated microarray test. Compared with HD, through analyzing enriched-Gene Ontology (GO) terms and KEGG pathways of each group, we found peripheral CD4+T cells might had different ability for mycobacterium tuberculosis infection in LTB1, LTB2 and TB. Finally we detected that TNFSF13/APRIL and TNFSF13B/BAFF was significant up-regulation in both CD4+T cells and serum of TB by real time PCR and ELISA, respectively.

2012-08-07 | GSE27882 | GEO

Gene expression profiling of Mycobacterium tuberculosis H37Rv in response to compound CDRI-5g

Project description:Gene expression profiling of Mycobacterium tuberculosis H37Rv in response to compound CDRI-5g (Saquib, M. et al. Eur. J. Med. Chem. 46 (2011) 2217-2223) was studied by administration of compound at 10 µg/ml in broth culture. RNA was extracted at two time points 12 h and 24 h of growth from replicating phase and compound added culture. Replicating phase culture was incubated for the same time and used as a control. Experiment was repeated three times and for each time points triplicate culture was pelleted to isolate total RNA using Qiagen RNA isolation kit. One-color experiment,Genotypic Technology designed Custom Mycobacterium tuberculosis H37Rv Whole Genome 8x15k GE Microarray (AMADID-019943)

2011-08-31 | E-GEOD-29166 | biostudies-arrayexpress

Gene expression profiling of Mycobacterium tuberculosis H37Rv in response to compound CDRI-5g

2011-09-01 | GSE29166 | GEO

Overexpression of small RNA MTS1338 M.tuberculosis (stationary phase)

Project description:We investigated the expression of MTS1338, a small non-coding RNA of Mycobacterium tuberculosis in bacterial cultures, and demonstrated its significant contribution to host-pathogen interactions.

2019-10-05 | GSE137857 | GEO

Analysis of global transcriptional response of Mycobacterium tuberculosis H37Rv to the natural compound ethyl p-methoxycinnamate

Project description:Gene expression profiling analysis was performed after exposing M. tuberculosis H37Rv to EPMC for 24 and 48 hours. Significant changes in expression levels were observed in the genome in response to the drug. Analysis of the data carried out by studying the expression pattern at the level of pathways, indicated that several pathways including amino sugar and nucleotide sugar metabolism, linoleic acid metabolism, fructose and mannose metabolism, galactose metabolism, lysine degradation pathways were significantly upregulated upon exposure to EPMC, while the pathways involved primarily in the mycobacterial cell wall biosynthesis - the mycolic acid biosynthesis and D-alanine metabolism were significantly downregulated

2014-12-31 | GSE41582 | GEO

Mycobacterium tuberulosis H37Rv strains: Control vs. Osthole.

Project description:Transcriptional profiling of Mycobacterium tuberculosis H37Rv strains comparing control DMSO treated strains with Osthole treated strains. Goal was to determine the effects of Osthole against Mycobacterium tuberculosis H37Rv strains.

2011-09-14 | GSE32076 | GEO

Mycobacterium tuberculosis H37Rv strains: Control vs. Linezolid.

Project description:Transcriptional profiling of Mycobacterium tuberculosis H37Rv strains comparing control DMSO treated strains with Linezolid treated strains. Goal was to determine the effects of Linezolid against Mycobacterium tuberculosis H37Rv strains.

2011-10-11 | GSE32718 | GEO

Mycobacterium tuberculosis H37Rv strains: Control vs. Lupulone

Project description:Transcriptional profiling of Mycobacterium tuberculosis H37Rv strains comparing control DMSO treated strains with Lupulone treated strains. Goal was to determine the effects of Lupulone against Mycobacterium tuberculosis H37Rv strains.

2011-08-30 | GSE31732 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data